首页> 外国专利> DUAL AFFINITY REDIRECTION REAGENT, NUCLEIC ACID MOLECULE, PHARMACEUTICAL COMPOSITION AND USES OF THE REDUCTION REAGENT OF DOUBLE AFFINITY

DUAL AFFINITY REDIRECTION REAGENT, NUCLEIC ACID MOLECULE, PHARMACEUTICAL COMPOSITION AND USES OF THE REDUCTION REAGENT OF DOUBLE AFFINITY

机译:双亲和力还原剂,核酸,药物组成和双亲和力还原剂的用途

摘要

A reagent re -routing of double affinity, nucleic acid molecule, pharmaceutical composition and uses of the double affinity re -routing reagent refers to antibodies and their fragments that are immunoreative to mammals, and more particularity And, the human B7 -h3 receptor and its use, particularly in the treatment of cancer and inflammation. The invention thus particularly concerns reactive humanized antibodies B7 -h3 and their immunoreative fragments that are able to mediate,And more preferably increase the activation of the immune system against cancer cells that are associated with a variety of human cancers. 1 /1
机译:双亲和力重路由试剂的重路由,核酸分子,药物组合物和用途是指对哺乳动物具有免疫反应性的抗体及其片段,更具体地讲,是指人B7 -h3受体及其衍生物。用途,特别是在癌症和炎症的治疗中。因此,本发明特别涉及能够介导的反应性人源化抗体B7-h3及其免疫反应片段,更优选地,增加针对与多种人类癌症相关的癌细胞的免疫系统的活化。 1/1

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号